Endpoints for New Drug Approvals in AML

被引：0

作者：

Estey, Elihu ^{[1
,2
]}

机构：

[1] Univ Washington, Seattle, WA 98195 USA

[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

来源：

ANNALS OF HEMATOLOGY | 2017年 / 96卷

关键词：

ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; CELL TRANSPLANTATION; COMPLETE REMISSION; 1ST; SURVIVAL; CANCER;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S21 / S23

页数：3

共 50 条

[41] New Analysis of Food and Drug Administration Oncology Drug Approvals
Lang, Les
[J]. GASTROENTEROLOGY, 2010, 138 (05) : 1639 - 1640
[42] Drug approvals
Anon
[J]. Chemical and Engineering News, 2002, 80 (41):
[43] DRUG APPROVALS
MILLER, HI
[J]. NATURE, 1992, 356 (6366) : 189 - 189
[44] Endpoints used by the FDA for new drug approvals for treatment (TT) of advanced (ADV) cancer: Example of hormone refractory prostate cancer (HRPC).
Mann, BS
Dagher, R
Williams, G
Johnson, J
Pazdur, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 545S - 545S
[45] THE NEW DRUG APPROVALS OF 1990, 1991, AND 1992 - TRENDS IN DRUG DEVELOPMENT
KAITIN, KI
MANOCCHIA, M
SEIBRING, M
LASAGNA, L
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (02): : 120 - 127
[46] Response: Induction endpoints in AML
Bishop, JF
Young, GA
Matthews, JP
Bradstock, K
[J]. BLOOD, 1996, 88 (02) : 754 - 755
[47] New drug approvals for 2019: Synthesis and clinical applications
Yuan, Shuo
Yu, Bin
Liu, Hong-Min
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 205
[48] THE NEW DRUG APPROVALS OF 1987, 1988, AND 1989 - TRENDS IN DRUG DEVELOPMENT
KAITIN, KI
DICERBO, PA
LASAGNA, L
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02): : 116 - 122
[49] Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
Feldman, Daniel
Avorn, Jerry
Kesselheim, Aaron S.
[J]. JAMA NETWORK OPEN, 2022, 5 (04) : E227958
[50] TRENDS IN DRUG DEVELOPMENT - THE 1985-86 NEW DRUG APPROVALS
KAITIN, KI
RICHARD, BW
LASAGNA, L
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (08): : 542 - 548

← 1 2 3 4 5 →